Organ Preservation Devices Market

Organ Preservation Devices Market Outlook 2025 to 2035

The global organ preservation devices market is expected to reach USD 428.4 Million by 2035, up from estimated value of USD 224.0 Million in 2025. During the forecast period 2025 to 2035, the industry is projected to expand at a CAGR of 6.7%.

The growing number of organ transplantation procedures, the growth of the need to have the longer organ viability, and the development of machine perfusion technologies drive the organ preservation devices market. Also, the adoption is accelerated by increased investments in hospital infrastructure and favorable regulatory frameworks that allow the provision of improved graft survival rates, decreased rates of organ discard, and enhanced clinical outcomes in transplant centers worldwide.

Quick Stats for Organ Preservation Devices Market

• Industry Value (2025): USD 224.0 Million
• Projected Value (2035): USD 428.4 Million
• Forecast CAGR (2025 to 2035): 6.7%
• Leading Segment (2025): Normothermic Machine Perfusion (NMP) Devices (35% Market Share)
• Fastest Growing Country (2025-2035): U.K. (6.5% CAGR)
• Top Key Players: are XVIVO Perfusion AB, TransMedics, Inc., Paragonix Technologies, Inc., OrganOx Limited, Bridge to Life Ltd., Carnamedica, Transnovo, and EBERS Medical Technology SL

What are the key factors driving growth in the Organ Preservation Devices Market?

Among the major contributing factors, there is a rising range of organ transplantations that are conducted all over the world, and a severe lack of organ donors. High-tech preservation systems can be used to prolong the existence of organs, increase the success rate of grafts, and decrease the complications of the post-denial period. The machine perfusion and normothermic storage technological advances and the real-time monitoring of organs provide the clinical confidence and permit the utilization of marginal or extended-criteria donor organs.

The development of the infrastructure of transplantation, a deeper increase in spending on healthcare, and the expansion of knowledge among specialists and patients regarding the advantages of the modern organ preservation systems further drive the market expansion.

What are the key trends driving growth in the Organ Preservation Devices market?

New trends are the use of normothermic machine perfusion, portable organ preservation and combining AI and cloud-based analytics to predictive assessment. Use of biosensor based real time organ viability scoring, wireless monitoring and automation in perfusion devices are becoming common.

Another area of innovation that is being speeded up is partnerships between medtech companies and transplant centers. It is also characterized by a change towards individual and organ-specific preservation regimes, which favor improved outcomes.

The emphasis on sustainability, miniaturization, and modularity of devices is making them more usable and increasing their flexibility, whereas the global standardization of preservation methods is making them more adopted by both developed and emerging markets.

What factors hinder the growth of the Organ Preservation Devices market?

The potential of the market is limited by the presence of high prices of devices, complicated working conditions, and strict regulatory compliance. There is a problem of limited reimbursement policy and lack of awareness in certain areas that prevent widespread adoption. The efficiency of operations can be influenced by technical issues like calibration of devices, maintenance and training of staff.

Besides, the difference in clinical protocols and organ specifications could impede the standard implementation. Small hospitals and transplant facilities might experience a budget constraint, which denies them access to the sophisticated equipment. The compatibility with the various types of organs and the conditions of transportation is still a limiting factor to its worldwide implementation in developing medical systems.

What are the key regional trends driving the Organ Preservation Devices Market growth?

North America

The industry is dominated by North America because of the high number of organ transplants, well-developed healthcare facilities, and the early use of normothermic and hypothermic perfusion systems. There is high usage and innovation driven by strong R&D, hospital investment in preservation technologies of organs and regulatory support.

East Asia

The East Asian region is on a booming journey because hospitals and transplant facilities are investing in sophisticated preservation equipment. Market expansion in countries such as China, Japan and South Korea are being driven by government initiatives, growing transplant procedures and growing awareness of organ viability technologies.

Western Europe

Western Europe is experiencing stable growth due to high regulatory requirements, clinical best practices, and relationships between medtech industries and transplant centers. The implementation of AI-powered and mobile organ preservation can improve the quality of transplantation and efficiency in all areas of the region.

Country-wise Outlook

Innovation and Advanced Perfusion Technologies Drive the United States’ Organ Preservation Devices Market

Organ preservation devices market has a strong presence in the U.S. which is a leader in the world with its steady application in transplant centers, hospitals, and research institutions. New technologies like normothermic and hypothermic perfusion, AI-driven monitoring, and portable preservation devices are becoming more popular to enhance the viability of organs and the results of transplantation. The U.S. is the location of the latest inventive organ preservation and digital integration options in transplantation processes due to strong R&D, favorable regulatory environments, and partnerships between medtech manufacturers and healthcare organizations.

Engineering Excellence and Regulatory Compliance Propel Germany’s Organ Preservation Devices Market

The German market is growing due to the presence of precision engineering, good quality standards and compliance with the regulations. Hospitals and transplant centers are embracing machine perfusion devices and hi-tech cold storage to maximize the outcomes and the preservation of organs. Firms in the local market are concerned with the reliability, biocompatibility of the device, and the ease of integration into the hospital workflows, and partnerships with academic institutions facilitate innovation. Germany is also establishing itself as an innovator of technologically advanced and clinically safe organ preservation systems in Europe.

Technological Advancement and Transplant Modernization Fuel the United Kingdom’s Organ Preservation Devices Market

The UK market is growing as more advanced organ perfusion devices and preservation solutions are currently being utilized in transplant centers and research facilities. The need to increase the survival of grafts, longer graft preservation, and discarding of organs creates adoption. In the local context, the adoption of AI, sensor technologies, and cloud-based monitoring are the topics of local initiatives aimed at supplementing decision-making and organ management. Through teaming up with the world innovators and government aid in revitalizing healthcare, the UK has an additional strength on the next generation organ preservation technologies.

Category-Wise Market Outlook

Normothermic Machine Perfusion (NMP) Devices Lead Product-Type Growth

The subsegment that is rapidly growing is the normothermic machine perfusion (NMP) as it can stabilize organs to close to physiological conditions to enhance their viability and lessen the ischemic damage. The use of NMP to preserve liver, heart and lung organs is growing in hospitals and transplant centers due to its ability to provide real time monitoring on organ functionality, to rehabilitate marginal organs and ensure the expansion of the donor pool. The rapid adoption is being necessitated by the clinical advantages of increased transplantation success and decreased rates of organ discarding.

Kidneys Dominate Organ-Type Demand

The most rapidly expanding subsector of the organ type is renal preservation devices, as renal transplants are in a strong demand all over the world, and donors are limited. Constant perfusion systems and enhanced storage systems enhance the survival of grafts and increase the duration of cold ischemia. Kidneys are the most popular organ based on the high number of operations it has and its significance in minimizing post-transplant complications, and therefore kidneys make it to be the most adopted organ specific device by hospitals and transplant centers.

UW Solution Leads Transport Medium Growth

The University of Wisconsin (UW) solution subsegment is growing at the most rapid rate in terms of transport media since it is still used in maintaining organs, including kidneys, livers and pancreases. Its success in minimizing cellular swelling and ischemic damage in the case of the static cold storage and its suitability with machine perfusion systems make it the best choice. In a bid to improve the quality of organs, to aid in the preservation process of more time, and achieve more successful results of transplantation across the globe, clinicians and transplant teams use UW solution.

Competitive Analysis

Competitive Outlook: Organ Preservation Devices Market

The Organ Preservation Devices Market can be considered a very competitive one because of the existing medtech giants and specialised innovators. Such companies like XVIVO Perfusion AB, TransMedics, Inc., and Paragonix Technologies, Inc. are at the forefront of the latest machine perfusion technologies like normothermic and hypothermic system that allow to improve organ viability, extend their survival time, and widen the range of possible donors. Portable and AI-enabled preservation solutions that complement real-time monitoring and clinical decision-making are targeted by OrganOx Limited and Bridge to Life Ltd., whereas Preservation Solutions, Inc. and Organ Recovery Systems, Inc. offer various perfusion devices and storage vehicles to serve various types of organs across hospitals and transplant centers throughout the world.

Smaller ones like Essential Pharmaceuticals, LLC, Carnamedica, Transnovo and EBERS Medical Technology SL focus more on next generation of biosensor integration, cloud-oriented monitoring and portables that store the precise preservation. The competitive approaches in the market include AI-based viability scoring, wireless connection, modularity, and their integration with hospital processes, which place these companies in the global market to address the rising demand of safe, efficient, and scalable organ preservation technologies.

Key players in the Organ Preservation Devices market are XVIVO Perfusion AB, TransMedics, Inc., Paragonix Technologies, Inc., OrganOx Limited, Bridge to Life Ltd., Preservation Solutions, Inc., Organ Recovery Systems, Inc., Essential Pharmaceuticals, LLC, Carnamedica, Transnovo, EBERS Medical Technology SL.

Recent Development

• In January 2025, Paragonix Technologies achieved a medical milestone with the first-in-human use of its KidneyVault™ portable renal perfusion system. This innovation enables continuous kidney perfusion during transport, enhancing organ viability, reducing ischemic injury, and supporting improved transplantation outcomes, marking a significant advancement in kidney preservation technology.
• In December 2024, XVIVO Perfusion’s XPS ex-vivo lung perfusion system played a pivotal role in the UK’s first double-lung transplant using machine-revived lungs. The procedure demonstrated the system’s ability to rehabilitate marginal donor lungs, expand the donor pool, and improve transplantation outcomes through enhanced organ assessment and preservation.

Fact.MR has provided detailed information about the price points of key manufacturers of Organ Preservation Devices market positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.

Methodology and Industry Tracking Approach

Fact.MR 2025 Survey on Organ Preservation Devices Market surveyed more than 10,000 participants with no less than 250 participants in each of the 30 countries. About two-thirds of the participants were end-users (hospitals, transplant centers, medical schools and rehabilitation centers) and the other third were industry experts (equipment designers, regulatory experts, technical consultants and healthcare technology advisors). The research was carried out between September 2024 and August 2025 and aimed at discussing the trends in adoption, technology integration, regulatory aspects, and technologies contributing to the development of advanced and sustainable organ preservation solutions.

In order to complement the main study, over 250 secondary data such as patents, product releases, policy documents, and sustainability reports have been examined with the help of high-performance modeling and predictive software. Fact.MR has been watching the Organ Preservation Devices market since 2018, following the trend of adoption, regulatory developments, and maturity. The 2025 report provides practical information, strategic advice, and suggestions to the interested parties to enable them to make informed investments, planning, and long-term development in this fast-paced and dynamic market.